BioCentury
ARTICLE | Clinical News

Soolantra ivermectin 1% regulatory update

April 13, 2015 7:00 AM UTC

Galderma said once-daily Soolantra ivermectin 1% cream was approved to treat inflammatory lesions of papulopustular rosacea under Europe’s decentralized procedure. Sweden acted as the reference member...